Mobility Performance in Children Wearing Spectacle Lenses for Myopia

This study is looking at how different types of glasses affect children's movement and daily activities. It compares standard spectacle lenses with a novel spectacle lens design, both of which aim to slow down myopia (nearsightedness) progression in children. Researchers will measure how quickly children react, how fast they move, and how accurately they respond to visual tasks after two months. You might be able to join if you are between 6 and 12 years old, have good corrected vision, and have had an eye exam recently. The study plans to enroll 20 children, but its current status is unclear.

Study design
This is an interventional study comparing two types of spectacle lenses. It plans to enroll 20 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants' reaction time, movement time, and response accuracy will be measured at 2 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07229352

Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses

Recruiting
NAAges 6–12InterventionalTreatment
SightGlass Vision, Inc.
~20 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:Novel spectacle lens designSpectacle lenses

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Reaction time: the time elapsed between the appearance or activation of a visual stimulus and the initiation of the participant's physical response
Measured over 2 months
+2 more outcomes measured
Myopia
Myopia Progression
Juvenile Myopia
1 sites across 1 states
Arizona1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Are between the ages of 6 and 12 years of age (inclusive) at the time of informed consent/assent.
Can achieve a corrected visual acuity of 20/20 best-corrected (or equivalent logMAR).
Have undergone a self-reported oculo-visual examination within the past two years.
Have no active ocular disease.
Are willing and able to adhere to instructions, study procedures, and maintain the appointment schedule.
Have not previously worn or participated in myopia control contact lenses for more than one month and are not currently undergoing any form of myopia control treatment.
The subject's parent(s) or legal guardian(s) must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form.

Exclusion

Have any systemic disease that affects ocular health.
Are currently using or have used, within the past 7 days, any systemic or topical medications that may impact ocular health.
Are currently using or have used any topical ophthalmic agents with anti-muscarinic properties within 7 days prior to enrollment or at any point during the study. This includes, but is not limited to, atropine, scopolamine, pirenzepine, tropicamide, cyclopentolate, and homatropine.
Have used any oral agents with anti-muscarinic properties for a chronic period (2 months or more) or short-term (within 7 days prior to enrollment). This includes, but is not limited to, gastrointestinal anti-spasmodic medications containing atropine, hyoscyamine, and dicyclomine.
Have known developmental delays.
Have participated in another clinical study in the last 7 days
  • Reaction time: the time elapsed between the appearance or activation of a visual stimulus and the initiation of the participant's physical response2 months
  • Movement time: the time taken to complete the motor response after it has been initiated.2 months
  • Response accuracy: the correctness of the participant's response to each visual stimulus, measured by the number or percentage of correctly identified or responded-to stimuli.2 months